Dipyrone, hyoscine-n-butyl
Sold as Buscopan compositum, Scopex co
Combination product
This product contains more than one active ingredient, so it has no single molecular structure.
Background
Registration
- Applicants
- 3
- Registrations
- 4
- Schedule source
- SAHPRA documentation
Applicants and registrations
| Applicant | Brands | Dosages | Registrations | Schedule | Leaflets |
|---|---|---|---|---|---|
| Ingelheim Pharmaceuticals (Pty) Ltd û FerndaleCertificate held by Sanofi-aventis South Africa (Pty) Ltd_ | Buscopan compositum | 20 mg/2.5 g | 83/332 | S4 | PIPIL |
| The Premier Pharmaceutical Co Ltd | Scopex co | Not stated | B1255 | Not determined | None |
| Opella Healthcare South Africa (Pty) Ltd | Buscopan compositum | 10 mg/250 mg, 20 mg/2,5 g | E0502, E0504 | Not determined | None |
Variants
| Product | Strength and form | Registration | Status | Schedule | Leaflets |
|---|---|---|---|---|---|
| Buscopan compositum EACH 1 ml SOLUTION CONTAINS DIPYRONE A 50 g HYOSCINE-N-BUTYL BROMIDE A 0,4 g | 20 mg/2.5 gInjection | 83/332Approved 3 February 2021 | Old Medicine | S4 | PIPIL |
| Scopex co TABLET DIPYRONE A 250 MG HYOSCINE-N-BUTYL BROMIDE A 10,2 MG | Not listed | B1255 | Old Medicine | Not determined | None |
| Buscopan compositum 10 mg/250 MG EACH TABLET CONTAINS DIPYRONE 250 mg HYOSCINE-N-BUTYL BROMIDE 10 mg | 10 mg/250 mg | E0502E/11.2/502 | Registered | Not determined | None |
| Buscopan compositum 20 mg/2,5 g EACH 5,0l SOLUTTION CONTAINS DIPYRONE 2500,0g HYOSCINE-N-BUTYL BROMIDE 20,0g | 20 mg/2,5 g | E0504E/11.2/504 | Registered | Not determined | None |
Regulatory status
Where S4 sits on the scale
Prescription-only medicine.
Schedule 4 covers most ordinary prescription medicines. You need a prescription from an authorised prescriber, such as a doctor or dentist, and a pharmacist dispenses it. Its price, name, pack size and strength can still be told to the public, as long as nothing links it to what it treats.
Schedule S4, read from the product's PI-PIL leaflet.
Who may supply: A pharmacist dispensing against a written or verbal prescription from an authorised prescriber; a veterinarian, who may also prescribe, compound or dispense it directly; a medical practitioner or dentist, who may prescribe it and may compound or dispense it directly only if licensed under section 22C(1)(a); manufacturers and wholesalers may supply people who may lawfully possess it; and, for animal treatment, a person practising a para-veterinary profession, on a veterinarian's written or verbal instruction.
This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.
SAHPRA documents
Schedule Verification
Buscopan compositum, Ingelheim Pharmaceuticals (Pty) Ltd û Ferndale is scheduled S4 in its official SAHPRA documents, read with 90% confidence.
These documents are provided by SAHPRA for informational purposes. Always consult with a healthcare professional for medical advice.